Vetoquinol's next confirmed earnings release is scheduled for March 25, 2027.
| Earnings Date | 3/25/2027 |
As of December 31, 2025, Vetoquinol has 11.62M shares outstanding.
| Shares Outstanding | 11.62M |
As of December 31, 2025, Vetoquinol maintains a current ratio of 3.08, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.08 |
| Quick Ratio | 1.49 |
| Debt / Equity | 2.59 |
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 2,501.00 |
As of the close on October 7, 2026, Vetoquinol's stock has gained approximately 0.78% over the past 52 weeks.
| 52-Week Price Change | 0.78% |
As of December 31, 2025, Vetoquinol holds 259.75M in cash and equivalents against 17.97M in total debt, resulting in a net debt position of -257.64M. Total book value stands at 694.83M, with working capital of 363.42M providing operational flexibility.
| Cash & Cash Equivalents | 259.75M |
| Total Debt | 17.97M |
| Net Debt | -257.64M |
| Equity (Book Value) | 694.83M |
| Book Value Per Share | 59.77 |
| Working Capital | 363.42M |
Already premium?